Mueller Brian's Form 4 filing
Biomarin Pharmaceutical Inc (BMRN) · filed Dec 6, 2022
- Accession no.
- 0001567619-22-021363
- Filed
- Dec 6, 2022
- Trade date
- Dec 2, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $731.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mueller BrianCIK 0001514980 | Officer (EVP, Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Common Stock | SSaleDisposed | −1,101 | $104.50 | −$115,054.5 | 27,746 | Direct | |
| Dec 2, 2022 | Common Stock | MOption exerciseAcquired | +2,139 | $67.81 | +$145,045.59 | 29,885 | Direct | |
| Dec 2, 2022 | Common Stock | SSaleDisposed | −2,139 | $104.50 | −$223,525.5 | 27,746 | Direct | |
| Dec 2, 2022 | Common Stock | MOption exerciseAcquired | +3,761 | $67.81 | +$255,033.41 | 31,507 | Direct | |
| Dec 2, 2022 | Common Stock | SSaleDisposed | −3,761 | $104.50 | −$393,024.5 | 27,746 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Common Stock | MOption exerciseDisposed | −2,139 | $0.00 | $0 | 0 | Direct | |
| Dec 2, 2022 | Common Stock | MOption exerciseDisposed | −3,761 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.